715 related articles for article (PubMed ID: 12835212)
21. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study.
Olshansky B; Day JD; Moore S; Gering L; Rosenbaum M; McGuire M; Brown S; Lerew DR
Circulation; 2007 Jan; 115(1):9-16. PubMed ID: 17179021
[TBL] [Abstract][Full Text] [Related]
22. [Electric programmed ventricular stimulation using a permanent cardiac pacing system--a noninvasive method in arrhythmia].
Novotný T; Dvorák R; Lábrová R; Kozák M; Semrád B
Cas Lek Cesk; 1999 Aug; 138(16):495-6. PubMed ID: 10566226
[TBL] [Abstract][Full Text] [Related]
23. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
Van Gelder BM; Meijer A; Dekker LR; Bracke FA
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
[TBL] [Abstract][Full Text] [Related]
24. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming.
Lewandowski M; Sterlinski M; Maciag A; Syska P; Kowalik I; Szwed H; Chojnowska L; Przybylski A
Europace; 2010 Sep; 12(9):1245-50. PubMed ID: 20650939
[TBL] [Abstract][Full Text] [Related]
26. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization.
Ricci RP; Morichelli L; Santini M
Europace; 2008 Feb; 10(2):164-70. PubMed ID: 18199570
[TBL] [Abstract][Full Text] [Related]
27. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
28. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
29. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
[TBL] [Abstract][Full Text] [Related]
31. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
Schulz N; Püschel K; Turk EE
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
[TBL] [Abstract][Full Text] [Related]
32. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
Grimm W; Plachta E; Maisch B
Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
[TBL] [Abstract][Full Text] [Related]
33. Right ventricular apical pacing: a necessary evil?
Healey JS; Yee R; Tang A
Curr Opin Cardiol; 2007 Jan; 22(1):33-8. PubMed ID: 17143042
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
[TBL] [Abstract][Full Text] [Related]
36. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application.
Manegold JC; Israel CW; Ehrlich JR; Duray G; Pajitnev D; Wegener FT; Hohnloser SH
Eur Heart J; 2007 Jul; 28(14):1731-8. PubMed ID: 17569681
[TBL] [Abstract][Full Text] [Related]
37. Management of malignant ventricular arrhythmias using antitachycardia devices.
McCowan RJ; Sampath R; Lee KC; Rashid H; Cafoncelli AR; Khan ZM; Malik FS; Chapman JL; Figueroa E; Freund PE
W V Med J; 1991 Sep; 87(9):395-9. PubMed ID: 1949755
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
39. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
Lazarus A
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S2-S12. PubMed ID: 17302706
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
